Malta - English - Medicines Authority

aristo pharma gmbh wallenroder straße 8–10, 13435, berlin, germany - tadalafil - film-coated tablet - tadalafil 5 mg - urologicals

Malta - English - Medicines Authority

aristo pharma gmbh wallenroder straße 8–10, 13435, berlin, germany - tadalafil - film-coated tablet - tadalafil 10 mg - urologicals

Malta - English - Medicines Authority

aristo pharma gmbh wallenroder straße 8–10, 13435, berlin, germany - tadalafil - film-coated tablet - tadalafil 20 mg - urologicals

Australia - English - Department of Health (Therapeutic Goods Administration)

lupin australia pty limited - paracetamol, quantity: 665 mg - tablet, modified release - excipient ingredients: hypromellose; magnesium stearate; microcrystalline cellulose; silicon dioxide; povidone; pregelatinised maize starch; purified water; croscarmellose sodium; titanium dioxide; macrogol 6000 - pharmacy action paracetamol osteo provides effective relief from persistent pain for up to 8 hours. effective for the relief of persistent pain associated with osteoarthritis and muscular aches and pains such as backache. provides effective temporary relief of pain and discomfort associated with: headache, tension headache, cold and flu, period pain, toothache and pain after dental procedures. reduces fever.

Australia - English - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - esomeprazole magnesium dihydrate, quantity: 21.69 mg - capsule, enteric - excipient ingredients: polysorbate 20; triethyl citrate; mannitol; diacetylated monoglycerides; purified water; sodium benzoate; polysorbate 80; titanium dioxide; sucrose; propylene glycol; sorbic acid; maize starch; octoxinol; dimeticone 350; propyl hydroxybenzoate; purified talc; stearoyl macrogolglycerides; gelatin; hypromellose; methyl hydroxybenzoate; iron oxide yellow; methacrylic acid - ethyl acrylate copolymer (1:1); ethanol; butan-1-ol; isopropyl alcohol; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - pharmacy choice esomeprazole heartburn relief is indicated for the symptomatic relief of frequent heartburn, acid regurgitation and other symptoms associated with gastro-oesophageal reflux disease (gord).

Australia - English - Department of Health (Therapeutic Goods Administration)

noumed pharmaceuticals pty ltd - pseudoephedrine hydrochloride, quantity: 30 mg; paracetamol, quantity: 500.4 mg - tablet, uncoated - excipient ingredients: povidone; pregelatinised maize starch; crospovidone; purified water; magnesium stearate; microcrystalline cellulose; stearic acid - temporary relief of the following cold and flu symptoms: nasal congestion, sinus pain, runny nose, headache and body aches and pains. reduces fever.

Israel - English - Ministry of Health

trima israel pharmaceutical products maabarot ltd - digoxin - tablets - digoxin 0.25 mg - digoxin - cardiac failure:digoxin kern pharma is indicated for the treatment of chronic cardiac failure where the principal cause is systolic dysfunction. the greatest therapeutic benefit is achieved in patients with ventricular dilatation.digoxin kern pharma is specifically indicated where cardiac failure is accompanied by atrial fibrilation.supraventricular arrhythmias:digoxin kern pharma is indicated for the treatment of certain supraventricular arrhythmias, particularly atrial fibrillation and flutter, where its principal beneficial effect is to reduce the ventricular rate.

Israel - English - Ministry of Health

mbi pharma ltd., israel - dexamethasone as sodium phosphate - solution for injection - dexamethasone as sodium phosphate 4 mg/ml - dexamethasone - dexamethasone kern pharma is indicated in the treatment of:• endocrine diseases such as nonsuppurative thyroiditis, hypercalcaemia associated with cancer and congenital adrenal hyperplasia.• allergy: severe or disabling allergic conditions resistant to conventional treatments, as in: bronchial asthma, contact or atopical dermatitis, seasonal or perennial allergic rhinitis, hypersensitivity reactions to drugs.• ophtalmic: serious inflammatory and allergic processes, acute and chronic, affecting the eyes, such as: iritis and iridocyclitis, chorioretinitis, choroiditis and diffuse posterior uveitis, optical neuritis, allergic conjunctivitis, allergic marginal corneal ulcers.• inflammatory bowel dis.: systemic treatment in exacerbations of ulcerative colitis and regional enteritis.• dermatological diseases (pemphigus, stevens johnson syndrome, exfoliative dermatitis, severe psoriasis and mycosis fungoides) • respiratory diseases (symptomatic sarcoidosis, berylliosis, loeffler's syndrome)• haematologica

Zimbabwe - English - Medicines Control Authority

pharma-q (pty) ltd t/a cosi pharmaceuticals - adrenaline acid tartrate - injectable; injection, ampoule - 1mg/ml

Zimbabwe - English - Medicines Control Authority

pharma-q (pty) ltd t/a cosi pharmaceuticals - atropine sulphate - injectable; injection - img/ml